Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • COF vs GSK✓SelectedUSD · GSKCOF vs GSK performance historyLatest closeAs of-1.71%11/20
Stock and ETF performance explorer

COF vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+155.2%
GSK return
+97.4%
Excess return
+57.8%
Maximum drawdown
-60.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.7%-0.1%-1.6%-1.7%
7D-8.0%-5.3%-2.7%-6.4%
30D-13.2%-3.7%-9.5%-12.3%
3M-15.6%-7.3%-8.3%-13.7%
6M-3.8%-4.2%+0.4%-3.1%
YTD-25.1%+0.9%-26.0%-26.3%
1Y-10.2%+7.3%-17.5%-13.5%
3Y+74.4%+52.7%+21.6%+39.6%
5Y+29.0%+40.1%-11.1%+4.8%
All+155.2%+97.4%+57.8%+84.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling